alabdy
07-19-2022, 04:08 AM
Europe’s vaccination process was expected to be well-orchestrated and efficient. So far, it’s been neither. Sabrina Tavernise, a national correspondent for The Times, spoke with our colleague Matina Stevis-Gridneff about Europe’s problems and why things could get worse before they get better.
Guest: Matina Stevis-Gridneff (https://www.nytimes.com/by/matina-stevis-gridneff), the Brussels correspondent for The New York Times, covering the European Union.
Sign up here (https://www.nytimes.com/newsletters/signup/NTTD?smid=pc-thedaily) to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter (https://www.nytimes.com/newsletters/the-daily?module=inline).
Background reading:
A cascade of small decisions has led to increasingly long delays in the European Union’s inoculation efforts (https://www.nytimes.com/2021/03/20/world/europe/europe-vaccine-rollout-astrazeneca.html?smid=pc-thedaily). While Washington went into business with the drug companies, Brussels took a conservative, budget-conscious approach that left the open market largely untouched. And it has paid for it.
Falling behind the pace of vaccine rollouts (https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html?smid=pc-thedaily) in countries like Britain, the United States and Israel, Europe is now tightening export rules (https://www.nytimes.com/2021/03/24/world/europe/vaccine-European-Union-export.html?smid=pc-thedaily) in a bid to speed up its inoculation campaign and stem political criticism.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily). Transcripts of each episode will be made available by the next workday.
أكثر... (https://www.nytimes.com/the-daily)
Guest: Matina Stevis-Gridneff (https://www.nytimes.com/by/matina-stevis-gridneff), the Brussels correspondent for The New York Times, covering the European Union.
Sign up here (https://www.nytimes.com/newsletters/signup/NTTD?smid=pc-thedaily) to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter (https://www.nytimes.com/newsletters/the-daily?module=inline).
Background reading:
A cascade of small decisions has led to increasingly long delays in the European Union’s inoculation efforts (https://www.nytimes.com/2021/03/20/world/europe/europe-vaccine-rollout-astrazeneca.html?smid=pc-thedaily). While Washington went into business with the drug companies, Brussels took a conservative, budget-conscious approach that left the open market largely untouched. And it has paid for it.
Falling behind the pace of vaccine rollouts (https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html?smid=pc-thedaily) in countries like Britain, the United States and Israel, Europe is now tightening export rules (https://www.nytimes.com/2021/03/24/world/europe/vaccine-European-Union-export.html?smid=pc-thedaily) in a bid to speed up its inoculation campaign and stem political criticism.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily). Transcripts of each episode will be made available by the next workday.
أكثر... (https://www.nytimes.com/the-daily)